We are delighted to announce that SCARLETRED will join the 9th Dermatology Drug Development Summit (DDDS 2025) as lead partner, continuing our commitment to advancing digital transformation in dermatology research.

The event will take place from November 18-20, 2025, in Boston, USA, bringing together over 120 global leaders from biopharma, clinical research, and investment sectors to accelerate progress in dermatology drug development.

This year’s program will feature cutting-edge discussions on novel therapeutics, JAK inhibitors, inflammation pathways, and translational breakthroughs across a wide range of skin conditions - including atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, and more.

Scarletred will contribute with a clear message:
AI and digital platforms are not the future in clinical research - they’re the present.

Our CEO, Dr. Harald Schnidar, will once again take the stage to share insights on the role of AI and digital innovation in transforming dermatology drug development and clinical trial design.

Participants are invited to meet our team and experience Scarletred®Vision, our validated and certified digital platform for standardized, objective, and quantitative skin analysis.

Discover & Win:

Visit our booth, experience Scarletred®Vision live, get a chance to win the Scarletred® Discovery Partner Package, designed to help research teams bring digital skin assessment into their clinical workflows.

For more information about the 9th Dermatology Drug Development Summit 2025, visit the official event website

‍